Citation Impact
Citing Papers
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Genetic regulation of MUC1 alternative splicing in human tissues
2008
The role of HER2 in cancer therapy and targeted drug delivery
2010
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
2005
The multifaceted roles of chemokines in malignancy
2006
Organ selectivity in metastasis: regulation by chemokines and their receptors
2007
New Developments in Anthracycline-Induced Cardiotoxicity
2009
Pancreatic cancer
2004 Standout
Doxorubicin pathways
2010 Standout
Cancer to bone: a fatal attraction
2011 Standout
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
2011
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
The effect of ultraviolet functionalization of titanium on integration with bone
2008
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
2016
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Antibacterial coatings on titanium implants
2009 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer
2010
Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses
2003
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
2018
Molecular mechanisms of cisplatin resistance
2011 Standout
Synthesis and biological evaluation of an albumin‐binding prodrug of doxorubicin that is cleaved by prostate‐specific antigen (PSA) in a PSA‐positive orthotopic prostate carcinoma model (LNCaP)
2007
A review on the wettability of dental implant surfaces II: Biological and clinical aspects
2014 Standout
Pancreatic Adenocarcinoma
2014 Standout
MUC1: a multifaceted oncoprotein with a key role in cancer progression
2014
Molecular detection of micro-metastasis in breast cancer
2002
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Revealing the human mucinome
2022 StandoutNobel
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
The 6‐maleimidocaproyl hydrazone derivative of doxorubicin (DOXO‐EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage
2006
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer
2007
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Chemical Approaches To Perturb, Profile, and Perceive Glycans
2009 StandoutNobel
DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials
2007
Pancreatic Cancer
2010 Standout
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
Immunological Functions of the Omentum
2017 Standout
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
2012
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Expression of CD133–1 and CD133–2 in ovarian cancer
2007
Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)
2006
Cancer-related inflammation
2008 StandoutNature
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pancreatic cancer
2011 Standout
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer
2017
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Specific Cell Targeting with Nanobody Conjugated Branched Gold Nanoparticles for Photothermal Therapy
2011
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Triboelectric Nanogenerator: A Foundation of the Energy for the New Era
2018 Standout
Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity
2000
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
A Doxorubicin Prodrug Activated by the Staudinger Reaction
2008
Combination therapy in combating cancer
2017 Standout
On the Electron‐Transfer Mechanism in the Contact‐Electrification Effect
2018 Standout
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
2004
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin
2007
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
2009 Standout
Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin
2007
Electrons on dielectrics and contact electrification
2009
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
2009
Profiling of Glycans in Serum for the Discovery of Potential Biomarkers for Ovarian Cancer
2006
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
Works of Bernd Schmid being referenced
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
2007
Novel MUC1 Splice Variants Are Expressed in Cervical Carcinoma
2001
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
2007
Prodrugs of Anthracyclines in Cancer Chemotherapy
2006
Expression of MUCI Splice Variants Correlates with Invasive Growth of Breast Cancer Cell Lines
2002
CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia
2004
Expression of mucins and cytokeratins in ovarian cancer cell lines
1999
Expression of MUC1 splice variants in benign and malignant ovarian tumours
2002
New perspectives in ovarian cancer treatment
2013
Bone cement implantation syndrome
1995
Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood.
1999
Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast
2003
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx): A randomized phase II trial in advanced pancreatic cancer
2005